Clinical Trial: A Study of Oral E1018 in Healthy Adult Participants

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854042) titled 'A Study of Oral E1018 in Healthy Adult Participants' on Feb. 25.

Brief Summary: The primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.

Study Start Date: Feb. 26

Study Type: INTERVENTIONAL

Condition: Malaria Healthy Participants

Intervention: DRUG: E1018

Specified dose on specified days.

DRUG: Placebo

E1018 matching placebo on specified days.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eisai Inc.

Published by HT Digital ...